Sanibel Captiva Trust Company’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.35M Sell
55,975
-1,683
-3% -$44K 0.03% 228
2026
Q1
$1.62M Sell
57,658
-8,214
-12% -$219K 0.05% 199
2025
Q4
$1.64M Sell
65,872
-1,949
-3% -$49.1K 0.05% 192
2025
Q3
$1.73M Buy
67,821
+351
+0.5% +$8.66K 0.05% 189
2025
Q2
$1.64M Sell
67,470
-906
-1% -$21.1K 0.05% 185
2025
Q1
$1.73M Sell
68,376
-1,181
-2% -$30.9K 0.06% 179
2024
Q4
$1.85M Sell
69,557
-7,632
-10% -$207K 0.06% 170
2024
Q3
$2.23M Sell
77,189
-6,016
-7% -$175K 0.07% 158
2024
Q2
$2.33M Buy
83,205
+10,949
+15% +$301K 0.08% 153
2024
Q1
$2.01M Buy
72,256
+4,157
+6% +$115K 0.07% 152
2023
Q4
$1.96M Buy
+68,099
New +$2.06M 0.07% 147

Other funds holding PFE

Sanibel Captiva Trust Company's PFE Position: Q2 2026 in Review

Sanibel Captiva Trust Company reduced its Pfizer (PFE) stake by 2.9% in Q2 2026, selling an estimated $44K and leaving 55,975 shares worth $1.35M. The position accounts for 0.03% of the portfolio, ranked #228.

Sanibel Captiva Trust Company first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.33M in Q2 2024. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Sanibel Captiva Trust Company held 55,975 shares of Pfizer worth $1.35M as of Q2 2026.
  • Sanibel Captiva Trust Company sold 1,683 Pfizer shares in Q2 2026, an estimated $44K.
  • Pfizer made up 0.03% of Sanibel Captiva Trust Company's portfolio in Q2 2026, its #228 holding.
  • Sanibel Captiva Trust Company first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Sanibel Captiva Trust Company's Pfizer position peaked at $2.33M in Q2 2024.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sanibel Captiva Trust Company's 13F filing for Q2 2026, filed 27 Jul 2026.